Exportar registro bibliográfico


Metrics:

Primary Results of ROSE/TRIO-12, a Randomized Placebo-Controlled Phase III Trial Evaluating the Addition of Ramucirumab to First-Line Docetaxel Chemotherapy in Metastatic Breast Cancer (2015)


Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2021